Select your language

What is Cartrophen Equine Forte?

Cartrophen Equine Forte (4mL vial of 250mg/mL of sodium pentosan polysulfate or PPS) is a concentrated form of Cartrophen Vet (10mL vial of 100mg/mL of PPS) specifically formulated for horses. The Biopharm recommended dosage for Cartrophen in horses remains 2-2.5mg/kg of PPS, equivalent to 1g of PPS per injection for a 400-500kg horse. The dosage is still administered by way of intramuscular injection on four occasions at intervals of 5-7 days.

Cartrophen Equine Forte is currently registered in New Zealand, Australia and U.A.E. It is indicated as an aid in the treatment for non-infectious inflammatory joint disease including osteoarthritis.

 

Further Information

Cartrophen Equine Forte DMOAD Brochure – The DMOAD brochure provides further overview of Cartrophen Equine Forte - Download PDF